Log in

NASDAQ:NEPT - Neptune Wellness Solutions Stock Price, Forecast & News

$1.30
+0.06 (+4.84 %)
(As of 03/30/2020 06:43 AM ET)
Today's Range
$1.21
Now: $1.30
$1.35
50-Day Range
$1.03
MA: $1.71
$2.26
52-Week Range
$0.96
Now: $1.30
$6.57
Volume1.90 million shs
Average Volume1.09 million shs
Market Capitalization$123.58 million
P/E RatioN/A
Dividend YieldN/A
Beta1.7
Neptune Wellness Solutions Inc., a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.
Read More

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NEPT
CUSIPN/A
Phone45-0687-2262

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$18.39 million
Book Value$0.66 per share

Profitability

Net Income$-17,670,000.00
Net Margins-132.09%

Miscellaneous

Employees58
Market Cap$123.58 million
Next Earnings Date6/10/2020 (Estimated)
OptionableOptionable

Receive NEPT News and Ratings via Email

Sign-up to receive the latest news and ratings for NEPT and its competitors with MarketBeat's FREE daily newsletter.


Neptune Wellness Solutions (NASDAQ:NEPT) Frequently Asked Questions

How has Neptune Wellness Solutions' stock been impacted by COVID-19 (Coronavirus)?

Neptune Wellness Solutions' stock was trading at $1.21 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, NEPT stock has increased by 7.4% and is now trading at $1.30. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Neptune Wellness Solutions?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Neptune Wellness Solutions.

When is Neptune Wellness Solutions' next earnings date?

Neptune Wellness Solutions is scheduled to release its next quarterly earnings announcement on Wednesday, June 10th 2020. View our earnings forecast for Neptune Wellness Solutions.

How were Neptune Wellness Solutions' earnings last quarter?

Neptune Wellness Solutions Inc (NASDAQ:NEPT) posted its quarterly earnings results on Thursday, February, 13th. The biotechnology company reported ($0.08) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by $0.05. The biotechnology company earned $6.95 million during the quarter, compared to the consensus estimate of $7.15 million. Neptune Wellness Solutions had a negative return on equity of 39.22% and a negative net margin of 132.09%. View Neptune Wellness Solutions' earnings history.

What price target have analysts set for NEPT?

3 brokerages have issued 1-year target prices for Neptune Wellness Solutions' stock. Their forecasts range from $3.75 to $3.75. On average, they anticipate Neptune Wellness Solutions' share price to reach $3.75 in the next year. This suggests a possible upside of 188.5% from the stock's current price. View analysts' price targets for Neptune Wellness Solutions.

Has Neptune Wellness Solutions been receiving favorable news coverage?

Press coverage about NEPT stock has been trending somewhat negative recently, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Neptune Wellness Solutions earned a daily sentiment score of -1.0 on InfoTrie's scale. They also assigned news coverage about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutNeptune Wellness Solutions.

Who are some of Neptune Wellness Solutions' key competitors?

What other stocks do shareholders of Neptune Wellness Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Cronos Group (CRON), Tilray (TLRY), Amarin (AMRN), Zynerba Pharmaceuticals (ZYNE), Aphria (APHA), Cara Therapeutics (CARA), OrganiGram (OGI) and Acasti Pharma (ACST).

Who are Neptune Wellness Solutions' key executives?

Neptune Wellness Solutions' management team includes the following people:
  • Mr. James S. Hamilton, Pres, CEO & Director
  • Mr. Mario Paradis, VP & CFO
  • Mr. Marc Vaugeois, VP of Sales
  • Mr. Michel Timperio, Pres of Cannabis Bus.
  • Mr. François-Karl Brouillette, VP of Science & Innovation of Nutraceutical Bus.

What is Neptune Wellness Solutions' stock symbol?

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

Who are Neptune Wellness Solutions' major shareholders?

Neptune Wellness Solutions' stock is owned by a number of institutional and retail investors. Top institutional shareholders include AdvisorShares Investments LLC (0.38%), Essex Investment Management Co. LLC (0.26%), Renaissance Technologies LLC (0.20%), Oxford Asset Management LLP (0.11%), Penserra Capital Management LLC (0.07%) and Cambria Investment Management L.P. (0.06%).

Which major investors are selling Neptune Wellness Solutions stock?

NEPT stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, and Cubist Systematic Strategies LLC.

Which major investors are buying Neptune Wellness Solutions stock?

NEPT stock was purchased by a variety of institutional investors in the last quarter, including AdvisorShares Investments LLC, Essex Investment Management Co. LLC, Oxford Asset Management LLP, Cambria Investment Management L.P., TD Asset Management Inc., Virtu Financial LLC, Credit Suisse AG, and Penserra Capital Management LLC.

How do I buy shares of Neptune Wellness Solutions?

Shares of NEPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Neptune Wellness Solutions' stock price today?

One share of NEPT stock can currently be purchased for approximately $1.30.

How big of a company is Neptune Wellness Solutions?

Neptune Wellness Solutions has a market capitalization of $123.58 million and generates $18.39 million in revenue each year. The biotechnology company earns $-17,670,000.00 in net income (profit) each year or ($0.14) on an earnings per share basis. Neptune Wellness Solutions employs 58 workers across the globe. View additional information about Neptune Wellness Solutions.

What is Neptune Wellness Solutions' official website?

The official website for Neptune Wellness Solutions is http://www.neptunecorp.com/.

How can I contact Neptune Wellness Solutions?

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262 or via email at [email protected]


MarketBeat Community Rating for Neptune Wellness Solutions (NASDAQ NEPT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  143 (Thanks for Voting!)
Underperform Votes:  133 (Thanks for Voting!)
Total Votes:  276
MarketBeat's community ratings are surveys of what our community members think about Neptune Wellness Solutions and other stocks. Vote "Outperform" if you believe NEPT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NEPT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/30/2020 by MarketBeat.com Staff

Featured Article: LIBOR

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel